A Medigene platform · Omnichannel HCP engagement

One knowledge network for everyone in the care chain

A prescription travels from the doctor who writes it, to the pharmacist who dispenses it, with a field representative connecting both. MedShorts gives all three the same accurate, bite-sized science, through one personalised link they can open on any phone.

Who MedShorts servesProgrammes for pharma

The MedShorts network

DoctorsClinical updates in five minutes or less
PharmacistsDispensing, counselling and safety capsules
Field forceProduct knowledge, certification and shareable links
One dashboardReach, engagement and learning, by audience
MedShorts 360 · Today

Today's news, 9 November 2026

One new story for each specialty, every morning: short, sourced and readable between patients.

CardiologyCardiology

SIMPLAAFY trial: aspirin alone or reduced-dose NOAC noninferior to DAPT after LAA closure

In a US JAMA trial of 1,857 AF patients after successful left atrial appendage closure, aspirin alone or a 3-month reduced-dose NOAC was noninferior to 6 months of DAPT at 6 months, with less bleeding.

Medical Dialogues
DiabetologyDiabetology

Parental autoimmune disease linked to higher type 1 diabetes risk in children: Swedish cohort

Among 1.46 million Swedish children followed for a median 15 years, a mother or father with autoimmune disease was linked to about 50-57% higher risk of type 1 diabetes, pointing largely to shared familial susceptibility.

Medical Dialogues
NephrologyNephrology

Pregnancy after living kidney donation carries modestly higher hypertensive risk: JAMA cohort

In a Canadian matched cohort, pregnancies after living kidney donation had 11.9% versus 8.3% hospitalisation with gestational hypertension or preeclampsia (risk ratio 1.51), and more small-for-gestational-age babies.

Medical Dialogues
NeurologyNeurology

Unruptured brain aneurysms more common than thought and rising: Lancet Neurology meta-analysis

Pooling 162 studies with 316,131 people, unruptured intracranial aneurysm prevalence was 3.9% in a reference population, up to 12.8% in ADPKD, and rose over two decades in healthy people scanned by angiography.

Medical Dialogues
UrologyUrology

Low-intensity shock wave therapy eases urinary symptoms and pelvic pain in men: Japanese pilot

In a retrospective Japanese study of 61 men with lower urinary tract symptoms, including chronic pelvic pain, six weekly sessions of low-intensity shock wave therapy lowered IPSS from 11.1 to 7.3 and NIH-CPSI from 11.8 to 7.0 at one month.

Medical Dialogues
PsychiatryPsychiatry

HPTN 094 trial: mobile addiction-HIV units did not raise MOUD or PrEP uptake beyond peer navigation

In 409 people who inject drugs with opioid use disorder, a mobile unit offering buprenorphine and PrEP plus peer navigation did not improve 26-week MOUD or PrEP use over peer navigation alone; fewer deaths at 52 weeks is a preliminary signal.

JAMA Psychiatry
PulmonologyPulmonology

FeNO beats blood eosinophil count for diagnosing suspected asthma, Lancet Respiratory Medicine analysis

A meta-analysis of 30 studies with prospective validation found FeNO predicted airway hyper-responsiveness in suspected asthma far better than blood eosinophils (adult AUC 0.80 vs 0.65); eosinophils added nothing when combined with FeNO.

Medical Dialogues
Critical CareCritical Care

ICU admissions after cardiac arrest climb on extreme heat days, US multicentre ICU data suggest

In over 11,000 out-of-hospital cardiac arrest ICU admissions across 10 US health systems, admission rates rose with outdoor heat, roughly doubling at 98°F, with more treatment for low blood pressure and dialysis; survival did not differ. Conference data, not yet peer reviewed.

American Heart Association Newsroom
GastroenterologyGastroenterology

Anti-TL1A biologics show 67% clinical response in ulcerative colitis: Indian J Gastroenterol review

A meta-analysis of 12 studies found anti-TL1A antibodies gave pooled clinical response of 67% in ulcerative colitis and 58% in Crohn's disease, with higher remission odds than controls; serious adverse events were about 4-5%.

Medical Dialogues
DermatologyDermatology

IL-17 inhibitors lead network meta-analysis of biologics for scalp psoriasis clearance

A JEADV network meta-analysis of 16 randomised trials (10,266 patients) ranked ixekizumab and brodalumab highest for scalp clearance at 12-16 weeks, with etanercept and apremilast lowest; no agent raised serious adverse events.

AJMC
OphthalmologyOphthalmology

EHR nudges did not cut low-value testing before cataract surgery in a randomised trial

In a UCLA pragmatic trial covering 1,045 preoperative cataract surgery visits, electronic alerts did not significantly reduce routine test orders overall, though a nudge stressing patient anxiety reduced blood count and ECG orders.

JAMA Ophthalmology
ENTENT

Prefrontal brain activity may explain varied cognition in children with sleep-disordered breathing

A JAMA Otolaryngology study of 284 children referred for snoring found prefrontal activation on fNIRS tracked apnoea severity and modified its link with cognition, which may help explain why some children are affected more than others.

JAMA Otolaryngology–Head & Neck Surgery
OrthopaedicsOrthopaedics

High-volume injections add little to exercise for Achilles tendinopathy in BMJ sham trial

In an Australian trial of 192 adults with midportion Achilles tendinopathy, high-volume injections with or without corticosteroid gave no clear benefit over sham at 12 months when added to exercise; steroid gave only a short-term gain.

Medical Dialogues
GynaecologyGynaecology

CMC Vellore trial: intrathecal morphine beats quadratus lumborum block for post-caesarean pain

In a double-blind trial of 60 women having elective caesarean delivery, 100 µg intrathecal morphine gave lower pain scores over 24 hours, a longer wait before rescue analgesia and higher satisfaction than bilateral quadratus lumborum block.

Medical Dialogues
PaediatricsPaediatrics

Seven-day continuous Holter finds more significant arrhythmias in children than 24-hour recording

In 435 children at a Taiwanese hospital, a continuous 7-day Holter detected major arrhythmias in 6.2% versus 2.3% with a 24-hour Holter or event recorder, and changed management more often (7.1% vs 1.6–2.8%).

Medical Dialogues
SurgerySurgery

Laparoscopic appendectomy linked to more fragmented specimens than open surgery, study finds

In 1,113 appendicitis patients, laparoscopic removal had about 3.6 times the odds of a compromised specimen versus open surgery, with perforation, larger appendix diameter and older age as added risks; retrieval bags did not prevent it.

Medical Dialogues
General MedicineGeneral Medicine

Half of adults with long COVID improve within three years, RECOVER cohort shows

In 1,019 US adults with likely long COVID followed from one year after infection, 36.2% had sustained improvement by two years and 50.1% by three years, while about 26.9% had complete remission at three years.

Medical Dialogues
3Audiences, one platform
4Channels: SMS, email, WhatsApp, QR
560+Medigene programmes behind it
28Specialties covered
Why MedShorts is changing

Medical communication has outgrown the single doctor visit

Indian pharma has traditionally put almost all of its scientific effort into one moment: the representative's few minutes with a doctor. Yet outcomes depend on much more than that moment. The pharmacist decides how a medicine is explained, substituted and taken. The representative's own confidence in the science shapes every conversation. And the doctor, seeing dozens of patients a day, needs updates that fit between consultations, not another hour-long webinar.

MedShorts began as a smart way to send doctors a personalised content library through a single link. We are now extending it into a broader strategic initiative: a knowledge network that serves the doctor, the pharmacist and the field force together, with consistent science, the right depth for each role, and one view of engagement for the brand team.

The result is fewer disconnected campaigns and more joined-up education, where the doctor's prescription, the pharmacist's counselling and the representative's message all say the same thing.

What changes with MedShorts

01
From one audience to threeContent written separately for prescribers, dispensers and representatives, from the same evidence base.
02
From campaigns to a programmeA planned calendar of short updates across the year instead of one-off mailers.
03
From clicks to insightEngagement data by specialty, geography and audience, fed back into the next cycle.
04
From information to learningQuizzes, certification and links to Medigene CME where a deeper course exists.
Who MedShorts serves

Built for three roles that shape every treatment

Each audience gets its own experience, written for how they work and what they need to decide, while the science underneath stays the same.

For doctors

Clinical knowledge between consultations

Short clinical updates, guideline summaries, journal digests and KOL perspectives, curated by specialty and delivered to the phone.

  • Read or watch in under five minutes
  • Specialty-specific libraries
  • Patient education material to share
MedShorts for doctors →
For pharmacists

Confident counselling at the counter

Practical capsules on dosing, interactions, storage, adherence and safety, written for community and hospital pharmacists.

  • Counselling scripts and checklists
  • Drug interaction and safety alerts
  • Available in English and Hindi
MedShorts for pharmacists →
For field force

Scientific confidence in every call

Micro-learning on disease, molecule and evidence, with assessments, certification and approved links representatives can share with doctors.

  • Daily five-minute learning bursts
  • Quizzes and product certification
  • Compliant, trackable sharing
MedShorts for field force →
The connected care chain

One message, from the representative to the patient

When all three roles learn from the same source, the patient hears one consistent story about their treatment.

Field representative

Learns the evidence, passes certification, shares an approved MedShorts link.

Doctor

Reviews the update in minutes, prescribes with the latest guidance, shares patient material.

Pharmacist

Dispenses correctly and counsels on dose, timing, side-effects and adherence.

MedShorts hubShared evidence base, medical review, multi-language content and one analytics layer across all three audiences.See the programme model
Strategic pillars

Five things MedShorts is built on

Short, evidence-led content

Every piece is written from published evidence and guidelines, reviewed by our medical team and kept to the length a busy clinician will actually finish.

Reach where people already are

Personalised links by SMS, email and WhatsApp, QR codes at pharmacies and clinics, and representative-shared links. No app to download.

Learning, not just reading

Quizzes, case challenges and certification turn content into measurable learning, with deeper courses on Medigene Learn.

Insight for brand teams

Open, read-through, video-completion and quiz data by audience, specialty and region, reported in one dashboard.

Trust and compliance

Medical and regulatory review, content aligned with the approved prescribing information, consent-based contact and data handled under India's data-protection law.

India-first delivery

Designed for low-bandwidth mobile use, with English and Hindi as standard and regional languages for pharmacist and patient material.

How it works

Receive, open, learn, act

Receive

A personalised MedShorts link arrives by SMS, email or WhatsApp, or is shared by a representative.

Open

One tap opens a secure, mobile-friendly library. A one-time registration keeps it personal.

Learn

Short articles, videos, infographics and quizzes, chosen for the reader's role and specialty.

Act

Apply it in practice, share patient material, or continue to a full CME course.

Measure

Engagement flows into the brand dashboard and shapes the next content cycle.

Content formats

The right format for every minute available

Clinical shorts

Two-to-three-minute reads on a single clinical question.

KOL video bites

Expert perspectives in three-to-five-minute clips.

Journal digests

Landmark and recent trials summarised with key numbers.

Guideline snapshots

What changed, and what it means in clinic.

Quizzes & case challenges

Test and reinforce, with instant explanations.

Patient education

Leaflets and videos doctors and pharmacists can share.

Interactive tools

Lung-sound and ECG trainers, calculators and checklists.

Safety alerts

Interaction, storage and pharmacovigilance reminders.

Already live

A growing library across specialties

MedShorts already hosts series in neurology, cardio-metabolic care, respiratory medicine, orthopaedics, oncology, women's health, critical care, dermatology, dentistry and ophthalmology, including interactive trainers for lung sounds and ECG interpretation.

The new network brings these together in one library and adds dedicated tracks for pharmacists and field teams.

NeurologyCardio-metabolicRespiratoryOrthopaedicsOncologyWomen's healthCritical careDermatologyDentalOphthalmology

Browse the content library

Fewer, shorter and better-targeted messages, shared by everyone around the patient, do more than any single detailing call.The idea behind the MedShorts network

Bring your brand science to the whole care chain

Talk to us about a MedShorts programme that reaches your doctors, their pharmacists and your field force with one consistent, compliant message.

Talk to our team